Bulk and single-cell RNA sequencing data identified HMGB3 of chromatin regulators as a breast cancer biomarker associated with the cell cycle - Scorecard - MDSpire
Advertisement
Bulk and single-cell RNA sequencing data identified HMGB3 of chromatin regulators as a breast cancer biomarker associated with the cell cycle
Clinical Scorecard: Identification of HMGB3 as a Breast Cancer Biomarker Linked to the Cell Cycle Through Bulk and Single-Cell RNA Sequencing of Chromatin Regulators
At a Glance
Category
Detail
Condition
Key Mechanisms
Chromatin regulators (CRs) modulate tumorigenesis and progression, with HMGB3 linked to cell cycle control.
Target Population
Care Setting
Key Highlights
Eleven chromatin regulators identified for prognostic modeling in BRCA.
HMGB3 expression correlates with tumor invasion and malignant progression.
Guideline-Based Recommendations
Diagnosis
Utilize transcriptome sequencing data to identify differentially expressed chromatin regulators.
Management
Incorporate HMGB3 as a potential target for therapeutic intervention in BRCA.
Monitoring & Follow-up
Assess chromatin regulator expression levels in BRCA patients.
Risks
High expression of HMGB3 is associated with increased invasion and poor prognosis.
Patient & Prescribing Data
Breast cancer patients with varying risk profiles based on chromatin regulator expression.
Clinical Best Practices
Employ single-cell RNA sequencing for detailed analysis of tumor microenvironment.
